ArticleBMC anesthesiology2026
The median effective dose of ropivacaine for ultrasound-guided peripheral nerve block around the hip capsule in elderly patients with intertrochanteric fractures.
Article in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThis study aimed to establish the median effective dose (ED50) and 95% confidence interval (CI) of 0.25% ropivacaine for ultrasound-guided pericapsular nerve group (PENG) block for facilitating spinal anesthesia positioning in elderly patients with intertrochanteric femoral fractures.
methodsThe elderly patients received elective proximal femoral nail antirotation (PFNA) surgery under spinal anesthesia. By adjusting the needle bevel orientation toward the superior pubic ramus, an ultrasound-guided PENG block was administered five minutes before positioning. The dose of 0.25% ropivacaine was titrated according to the highest pain level reported on the visual analog scale (VAS) during positioning, starting from 10 ml with subsequent adjustments in 1 ml increments. The modified Dixon Up-and-Down sequential method was used to determine the effective dose, and the median ED50 along with its 95% CI for 0.25% ropivacaine were calculated using Probit analysis. VAS scores were recorded at baseline, 5 min after block administration, and during positioning. Postoperative sufentanil consumption and block-related complications—including bleeding, hematoma, quadriceps weakness, and local anesthetic toxicity—were also documented.
resultsA total of thirty elderly patients with intertrochanteric femoral fractures were enrolled. The ED50 of 0.25% ropivacaine for a PENG block to facilitate spinal anesthesia positioning was determined to be 3.674 ml (95% CI: 1.879–4.842 ml). At five minutes post-block, both the VAS score during passive movement and the highest VAS score recorded during positioning were significantly reduced compared to pre-block values. However, no significant differences were observed in postoperative VAS scores, postoperative sufentanil consumption, or the incidence of complications.
conclusionFor elderly intertrochanteric fracture patients, ED50 of 0.25% ropivacaine PENG block was 3.674 ml. By adjusting the needle bevel orientation, a low-dose local anaesthetic can effectively relieve pain without affecting quadriceps strength.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.